Literature DB >> 17765621

Molecular composition of the intercalated disc in a spontaneous canine animal model of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Eva M Oxford1, Melanie Everitt, Wanda Coombs, Philip R Fox, Marc Kraus, Anna R M Gelzer, Jeffrey Saffitz, Steven M Taffet, N Sydney Moïse, Mario Delmar.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by ventricular arrhythmias, sudden death, and fatty or fibrofatty replacement of right ventricular myocytes. Recent studies have noted an association between human ARVD/C and molecular remodeling of intercalated disc structures. However, progress has been constrained by limitations inherent to human studies.
OBJECTIVE: We studied the molecular composition of the intercalated disc structure in a naturally occurring animal model of ARVD/C (Boxer dogs).
METHODS: We studied hearts from 12 Boxers with confirmed ARVD/C and 2 controls. Ventricular sections from 4 animals were examined by immunofluorescent microscopy. Frozen tissue samples were used for Western blot analysis. Proteins investigated were N-cadherin, plakophilin 2, desmoplakin, plakoglobin, desmin, and connexin 43 (Cx43).
RESULTS: In control dogs, all proteins tested by immunofluorescence analysis yielded intense localized signals at sites of end-to-end cell apposition. In contrast, myocardial tissues from ARVD/C-afflicted Boxers showed preservation of N-cadherin staining but loss of detectable signal for Cx43 at the intercalated disc location. Western blots indicated that the Cx43 protein was still present in the samples. Gene sequencing analysis showed no mutations in desmoplakin, plakoglobin, Cx43, or plakophilin 2.
CONCLUSION: Mutation(s) responsible for ARVD/C in Boxers lead, directly or indirectly, to severe modifications of mechanical and electrical cell-cell interactions. Furthermore, significant reduction in gap junction formation may promote a substrate for malignant ventricular arrhythmias. This model may help to advance our understanding of the molecular basis, pathophysiology, and potential therapeutic approach to patients with ARVD/C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765621      PMCID: PMC2080779          DOI: 10.1016/j.hrthm.2007.05.025

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  35 in total

1.  Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis.

Authors:  Jifen Li; Vickas V Patel; Igor Kostetskii; Yanming Xiong; Antony F Chu; Jason T Jacobson; Cindy Yu; Gregory E Morley; Jeffery D Molkentin; Glenn L Radice
Journal:  Circ Res       Date:  2005-08-11       Impact factor: 17.367

2.  Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Familial ventricular arrhythmias in boxers.

Authors:  K M Meurs; A W Spier; M W Miller; L Lehmkuhl; J A Towbin
Journal:  J Vet Intern Med       Date:  1999 Sep-Oct       Impact factor: 3.333

4.  Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion.

Authors:  Andrew W Hunter; Ralph J Barker; Ching Zhu; Robert G Gourdie
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

5.  Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).

Authors:  Starr R Kaplan; Joseph J Gard; Nikos Protonotarios; Adalena Tsatsopoulou; Chara Spiliopoulou; Aris Anastasakis; Catherine Prost Squarcioni; William J McKenna; Gaetano Thiene; Cristina Basso; Nicole Brousse; Guy Fontaine; Jeffrey E Saffitz
Journal:  Heart Rhythm       Date:  2004-05       Impact factor: 6.343

6.  Modulation of cardiac gap junction expression and arrhythmic susceptibility.

Authors:  Stephan B Danik; Fangyu Liu; Jie Zhang; H Jacqueline Suk; Gregory E Morley; Glenn I Fishman; David E Gutstein
Journal:  Circ Res       Date:  2004-10-21       Impact factor: 17.367

7.  Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping.

Authors:  G E Morley; D Vaidya; F H Samie; C Lo; M Delmar; J Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  1999-10

8.  Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells.

Authors:  Chih-Jen Wei; Richard Francis; Xin Xu; Cecilia W Lo
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

Review 9.  Genetics of right ventricular cardiomyopathy.

Authors:  Srijita Sen-Chowdhry; Petros Syrris; William J McKenna
Journal:  J Cardiovasc Electrophysiol       Date:  2005-08

10.  Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Kalliopi Pilichou; Andrea Nava; Cristina Basso; Giorgia Beffagna; Barbara Bauce; Alessandra Lorenzon; Gianfranco Frigo; Andrea Vettori; Marialuisa Valente; Jeffrey Towbin; Gaetano Thiene; Gian Antonio Danieli; Alessandra Rampazzo
Journal:  Circulation       Date:  2006-02-27       Impact factor: 29.690

View more
  24 in total

1.  Ultrastructural changes in cardiac myocytes from Boxer dogs with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eva M Oxford; Charles G Danko; Bruce G Kornreich; Karen Maass; Shari A Hemsley; Dima Raskolnikov; Philip R Fox; Mario Delmar; N Sydney Moïse
Journal:  J Vet Cardiol       Date:  2011-06-01       Impact factor: 1.701

Review 2.  At the heart of inter- and intracellular signaling: the intercalated disc.

Authors:  Heather R Manring; Lisa E Dorn; Aidan Ex-Willey; Federica Accornero; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2018-06-06

3.  Resveratrol protects the loss of connexin 43 induced by ethanol exposure in neonatal mouse cardiomyocytes.

Authors:  Su Tu; Fu-Tao Cao; Xiao-Chun Fan; Cheng-Jian Yang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-28       Impact factor: 3.000

Review 4.  Gap junctions and arrhythmogenic cardiomyopathy.

Authors:  Angeliki Asimaki; Jeffrey E Saffitz
Journal:  Heart Rhythm       Date:  2011-11-16       Impact factor: 6.343

5.  Analysis of Protein-protein Interactions and Co-localization Between Components of Gap, Tight, and Adherens Junctions in Murine Mammary Glands.

Authors:  Elham Dianati; Isabelle Plante
Journal:  J Vis Exp       Date:  2017-05-30       Impact factor: 1.355

6.  Desmosomal molecules in and out of adhering junctions: normal and diseased States of epidermal, cardiac and mesenchymally derived cells.

Authors:  Sebastian Pieperhoff; Mareike Barth; Steffen Rickelt; Werner W Franke
Journal:  Dermatol Res Pract       Date:  2010-06-30

Review 7.  Reciprocal influence of connexins and apical junction proteins on their expressions and functions.

Authors:  Mickaël Derangeon; David C Spray; Nicolas Bourmeyster; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  Biochim Biophys Acta       Date:  2008-11-11

Review 8.  Mechanisms of gap junction traffic in health and disease.

Authors:  Geoffrey G Hesketh; Jennifer E Van Eyk; Gordon F Tomaselli
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

9.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 10.  The cardiac connexome: Non-canonical functions of connexin43 and their role in cardiac arrhythmias.

Authors:  Alejandra Leo-Macias; Esperanza Agullo-Pascual; Mario Delmar
Journal:  Semin Cell Dev Biol       Date:  2015-12-07       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.